Ownership history in XTX Topco Ltd Β· 3 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in SEASTAR MEDICAL HOLDING CORP (ICU). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π XTX Topco Ltd underperformed the S&P 500 by β118.9% annually on this ICU position. Average cost basis: $6.75. Maximum drawdown during holding period: β74.3%.
β Significantly underperformed the S&P 500 by 118.9% ann.
2 quarters analyzed
Best entry: $4.26 (2025 Q2) Β· Worst: $16.60 (2025 Q1)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
2 adds Β· 1 trim. Bought during 1 of 1 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size